Researchers developed a prediction tool for pediatric dilated cardiomyopathy using data from 106 children (median age 10 months), identifying NT-proBNP levels and biological sex as key survival predictors. The study found TTN gene mutations in 28.3% of cases, representing the most common genetic variant among 14 identified mutations linked to this severe heart condition that leads to heart failure and transplantation needs. This represents meaningful progress in pediatric cardiology risk stratification, where early mortality rates remain devastatingly high and clinical decision-making often relies on subjective assessment. The nomogram's ability to predict 1, 3, and 5-year mortality risks could help clinicians time interventions more precisely, potentially improving outcomes through earlier transplant listing or more aggressive medical management. However, the small cohort size of 106 patients significantly limits generalizability, and the single-center Chinese population may not reflect global pediatric DCM patterns. The model requires external validation across diverse populations before widespread clinical adoption. As this is a preprint awaiting peer review, the statistical methodology and clinical conclusions need independent verification before these findings can reliably inform pediatric heart failure management protocols.